Nebulised antipseudomonal therapy in cystic fibrosis.
Touw
D J
DJ
Bakker
W
W
D000280:Administration, Inhalation; D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000150:complications*; D006801:Humans; D011552:Pseudomonas Infections / Q000188:drug therapy*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents